Hospira Gemcitabine Injection 38 mg/mL, 200 mg/5.3 mL vial

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Mevcut itibaren:

Hospira Australia Pty Ltd

INN (International Adı):

Gemcitabine hydrochloride

Farmasötik formu:

Injection, concentrated

Kompozisyon:

Excipient Ingredients: water for injections; hydrochloric acid; sodium hydroxide

Uygulama yolu:

Intravenous

Paketteki üniteler:

1 x 5.3 mL pack

Sınıf:

Medicine Listed (Export Only)

Reçete türü:

(S1) This Schedule is intentionally blank

Terapötik endikasyonlar:

Gemcitabine is indicated for treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelian ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first line therapy. Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.

Ürün özeti:

Visual Identification: A clear, colourless or light straw-coloured solution, practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Listed (Export Only)

Yetkilendirme tarihi:

2011-04-20